1-3 of 3
Jingwen Tan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long-Term Remission and Survival in Patients with Rituximab-Refractory/Relapsed B-Cell Non-Hodgkin Lymphoma after Treatment with U16 (CD20 CAR-T cells)

Qian Cheng, JingWen Tan, Rui Liu, Liqing Kang, Hongjia Zhu, Yi Zhang, Erhua Wang, Ying Li, Jian Zhang, Han Xiao, Rong He, Xiaoyan Lou, Nan Xu, Wei Wang, Zhou Yu, Minghao Li, Hongfei Gu, Lei Yu, Xin Li
Journal: Blood
Blood (2024) 144 (Supplement 1): 3447.
https://doi.org/10.1182/blood-2024-200516
Published: 2024
Journal Articles

Target Antigen-Expressing T Cells Facilitate CAR-T Cell Eradication of Residual CD19+ B Malignant Cells

Minghao Li, Wenjie Gong, JingWen Tan, Hongjia Zhu, Nan Xu, Liqing Kang, Xiaoyan Lou, Wei Wang, Jing Ye, Zhou Yu, Israth Jahan Tuhin, Liyun Chen, Chongsheng Qian, Meijing Liu, Ni Mei, Tong Shi, Guanghua Chen, Lei Yu, Shengli Xue, Depei Wu
Journal: Blood
Blood (2024) 144 (Supplement 1): 4794.
https://doi.org/10.1182/blood-2024-206406
Published: 2024
Journal Articles

shRNA-Interleukin-6 Modified CD19-Specific Chimeric Antigen Receptor T Cell Significantly Improves the Safety in Acute Lymphoblastic Leukemia

Liqing Kang, Xiaowen Tang, Nan Xu, Minghao Li, Jingwen Tan, Wei Qi, Zhou Yu, Xiaoyan Lou, Shengli Xue, Xin Li, MD, Jian Zhang, MD, Jia Chen, MD, Zhenkun Wang, PhD, Caixia Li, Fu Cheng Cheng, MD PhD, Depei Wu, MD PhD, Lei Yu, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2621.
https://doi.org/10.1182/blood-2019-132067
Published: 2019